2021-01-04,b'EPS growth qtr over qtr more than 25%\n$TOPS\n$INPX\n$CTRM\n$TMBR\n$SNES\n$TELL\n$APM\n$MKD\n$ICPT\n$GOVX\n$AMRN\n$NVCN\n$SLRX\n$PTE\n$CHFS\n$NAOV\n$EOLS\n$MYT\n$CPE\n$WISA\n$STNG\n$ASMB\n$WMC\n$NNA\n$CCRC\n$NCTY\n$ZGNX\n$HFFG\n$CRTD\n$MOTS\n$SXTC\n$VCNX\n$RCEL\n$ESPR\n$VIVE\n$EYPT\n$MYSZ\n$AXDX\n$IMTE\n$CHX\n$FRO\n$BIMI'
2020-12-31,b'$SLRX who dropped the hefty buys just now? Is there something we should know about? \xf0\x9f\xa4\x94 https://t.co/1EHWrO9dpU'
2020-12-30,"b""@Toad @7atim_alzahrani The confidence emanating from the Company twitter account going into JPM Healthcare Conference in a couple of weeks is quite interesting\n\nAdd to that the market seems unaware? of the combination trial with Merck's KEYTRUDA if this becomes more widely known it could fly? $SLRX"""
2020-12-30,b'RT @Toad: @7atim_alzahrani $SLRX - definitely coiled right now. Just needs a push. Could fly in either direction. \xf0\x9f\x91\x8d https://t.co/iv8XBdkXXb'
2020-12-30,b'@7atim_alzahrani $SLRX - definitely coiled right now. Just needs a push. Could fly in either direction. \xf0\x9f\x91\x8d https://t.co/iv8XBdkXXb'
2020-12-30,b'Currently holding $FCEL $NOVN  $CTRM $BXRX $SLRX $ATOS and $CATB                                                 Currently watching to enter $SNGX $ONTX'
2020-12-30,b'RT @SalariusPharma: #Seclidemstat represents a potential paradigm shift in the treatment of #EwingSarcoma and other #ChildhoodCancers \n\nLea\xe2\x80\xa6'
2020-12-30,b'Alertas $AAL $AFMD $APOP $BA $BLRX $CPE $F $GDDY $IMTE $MESA $RIG $RYAM $SLRX $CUBE $DG $DT $EBay $EXPE $FLGT $FWP $INTC $JD $LULU $NFLX $PDD $PINS $QCOM $QRTEA $SBUX $SNAP $SREV $SSRM $WST $TIGR https://t.co/NqYASZNJ9i'
2020-12-30,b'Alertas $AAL $AFMD $APOP $BA $BLRX $CPE $F $GDDY $IMTE $MESA $RIG $RYAM $SLRX $CUBE $DG $DT $EBay $EXPE $FLGT $FWP $INTC $JD $LULU $NFLX $PDD $PINS $QCOM $QRTEA $SBUX $SNAP $SREV $SSRM $WST $TIGR https://t.co/WF99DVa1QB'
2020-12-30,b'Alertas $AAL $AFMD $APOP $BA $BLRX $CPE $F $GDDY $IMTE $MESA $RIG $RYAM $SLRX $CUBE $DG $DT $EBay $EXPE $FLGT $FWP $INTC $JD $LULU $NFLX $PDD $PINS $QCOM $QRTEA $SBUX $SNAP $SREV $SSRM $WST $TIGR https://t.co/PJiOo0Xy8y'
2020-12-30,b'Alertas $AAL $AFMD $APOP $BA $BLRX $CPE $F $GDDY $IMTE $MESA $RIG $RYAM $SLRX $CUBE $DG $DT $EBay $EXPE $FLGT $FWP $INTC $JD $LULU $NFLX $PDD $PINS $QCOM $QRTEA $SBUX $SNAP $SREV $SSRM $WST $TIGR https://t.co/6L5TUUw0I5'
2020-12-30,b'Alertas $AAL $AFMD $APOP $BA $BLRX $CPE $F $GDDY $IMTE $MESA $RIG $RYAM $SLRX $CUBE $DG $DT $EBay $EXPE $FLGT $FWP $INTC $JD $LULU $NFLX $PDD $PINS $QCOM $QRTEA $SBUX $SNAP $SREV $SSRM $WST $TIGR https://t.co/LBZVfPg4rt'
2020-12-30,b'#Seclidemstat represents a potential paradigm shift in the treatment of #EwingSarcoma and other #ChildhoodCancers \n\nLearn more about how Salarius ( $SLRX ) is using this small #LSD1 inhibitor to regulate gene expression at https://t.co/aKOypdjsj5 https://t.co/I8rNilqrYP'
2020-12-30,b'Alertas $AAL $AFMD $APOP $BA $BLRX $CPE $F $GDDY $IMTE $MESA $RIG $RYAM $SLRX $CUBE $DG $DT $EBay $EXPE $FLGT $FWP $INTC $JD $LULU $NFLX $PDD $PINS $QCOM $QRTEA $SBUX $SNAP $SREV $SSRM $WST $TIGR https://t.co/dotxQQDkCk https://t.co/Lcu5VgBEJJ'
2020-12-30,b'Alertas $AAL $AFMD $APOP $BA $BLRX $CPE $F $GDDY $IMTE $MESA $RIG $RYAM $SLRX $CUBE $DG $DT $EBay $EXPE $FLGT $FWP $INTC $JD $LULU $NFLX $PDD $PINS $QCOM $QRTEA $SBUX $SNAP $SREV $SSRM $WST $TIGR https://t.co/dotxQQDkCk https://t.co/DtoCujdhZX'
2020-12-29,b'RT @Mike02222093: @stockpunter Have a position in $SLRX - major resistance zones (give or take a bit - zones can be squishy) w/red arrows.\xe2\x80\xa6'
2020-12-29,b'@stockpunter Have a position in $SLRX - major resistance zones (give or take a bit - zones can be squishy) w/red arrows. Will take a look at the other charts after I heat up some lunch... \xf0\x9f\x98\x81 https://t.co/O4W7EUD9tX'
2020-12-29,"b'RT @SalariusPharma: This @Concordia study examined feasibility, acceptability, and preliminary efficacy of wearable respiratory monitoring\xe2\x80\xa6'"
2020-12-29,"b'This @Concordia study examined feasibility, acceptability, and preliminary efficacy of wearable respiratory monitoring among survivors of #ChildhoodCancer with #ChronicPain\n\nFull article: https://t.co/2JUul4jc9Q \n\n#EwingSarcoma $SLRX https://t.co/aKOypdjsj5'"
2020-12-29,b'New stocks on my screener alert \xf0\x9f\x9a\xa8 \xf0\x9f\x9a\xa8 $SIEN $MSN $ANTE $SLRX $THYT https://t.co/vJ93l26ZOz'
2020-12-28,b'RT @SalariusPharma: Ewing Sarcoma is the second most common type of bone cancer in children\n\nJoin Salarius Pharmaceuticals ( $SLRX ) in our\xe2\x80\xa6'
2020-12-28,"b'Entered into $SLRX at 0.947 for a swing, daily chart looks incredible!'"
2020-12-28,b'$SLRX is looking amazing entering in now'
2020-12-28,b'Ewing Sarcoma is the second most common type of bone cancer in children\n\nJoin Salarius Pharmaceuticals ( $SLRX ) in our fight to develop more effective and less toxic treatments for #EwingSarcoma and other forms of #ChildhoodCancer. Visit https://t.co/aKOypdjsj5 to learn more https://t.co/DybCPC2oBu'
2020-12-27,"b'Top 10 watchers going into next week. Feel free to help narrow these down to a top 3 or 5. My top 3 are $FTFT , $QTT and $SNDL\n\n$IMMP \n$SLRX\n$IPDN\n$CXDC\n$SXTC\n$SNDL\n$BLRX\n$FTFT\n$QTT\n$ATRS\n\nhttps://t.co/8xpDRuWCv8'"
2021-01-08,b'$SLRX \n1.22 on open\n8 over the 21 MA above all MAs\n1.48m volume in first 30 min \naverage (3m) is 782k\nlook for 1.39 test https://t.co/nzlo2soHUZ'
2021-01-08,"b'10:12 Pops: $SLRX +8.3%, $GRNQ +6.1%, $KXIN +5.5%, $EMAN +5.1%, $JFU +4.7%, $ANY +4.7%, $SUNW +4.5%, $POLA +4.0%, $IZEA +3.6%'"
2021-01-08,b'Great move by $SLRX! Nice cup formation on the daily chart! https://t.co/AJtP4F2QoE'
2021-01-08,b'RT @Stockonomist: Some stocks sure setting up nice going into next weeks #JPM21 #JPM2021 and #BiotechShowcase \n\ne.g. $SLRX \xf0\x9f\xa4\x94\n\nA $20m minnow\xe2\x80\xa6'
2021-01-08,b'RT @buysellshort: $SLRX presents on MONDAY  $1.15 break for $1.40+ SWING PLAY https://t.co/E5eHCL44EQ'
2021-01-08,b'RT @buysellshort: $SLRX presents on MONDAY  $1.15 break for $1.40+ SWING PLAY https://t.co/E5eHCL44EQ'
2021-01-08,b'$SLRX presents on MONDAY  $1.15 break for $1.40+ SWING PLAY https://t.co/E5eHCL44EQ'
2021-01-08,"b'$SLRX \n1.09\nwill history repeat itself, \nadds on the trend(purple)\nwatch for 1.39 test https://t.co/CftnzVNmX7'"
2021-01-07,b'Some stocks sure setting up nice going into next weeks #JPM21 #JPM2021 and #BiotechShowcase \n\ne.g. $SLRX \xf0\x9f\xa4\x94\n\nA $20m minnow with LSD inhibitor drug involved in combination clinical trial with Merck KEYTRUDA'
2021-01-07,b'RT @CRInvestor: $SLRX #Bangioutdoubles More double fills coming in on crypto related names! #noice #pma4tw via https://t.co/B6wMX0rRJ5 http\xe2\x80\xa6'
2021-01-07,b'$SLRX #Bangioutdoubles More double fills coming in on crypto related names! #noice #pma4tw via https://t.co/B6wMX0rRJ5 https://t.co/bH8rurkGK1'
2021-01-07,b'$SLRX presenting at J.P. Morgan Annual Healthcare Conference and Biotech showcase next week. https://t.co/nFvS4hHbCN'
2021-01-07,"b'$SLRX shows a strong growth in Revenue. In the last year, the Revenue has grown by 37.55%. https://t.co/B1Ns5FDKen https://t.co/dV4YYTn81e'"
